Skip to main content
Premium Trial:

Request an Annual Quote

Sirna Wraps Up $18.7M Private Placement

NEW YORK, May 5 (GenomeWeb News) -- Sirna Therapeutics has closed an $18.7 million private placement of its common stock to undisclosed institutional investors, the company said today.


The Boulder, Colo.-based RNAi developer sold 5.8 million of its common shares in the transaction.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.